A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal cancers, according to results of a clinical trial. The findings offer hope that this therapy could be used to treat a variety of solid tumors, which has so far eluded researchers developing cell-based therapies.

By integrating powerful 3D imaging technology with advanced computation, researchers can capture gaze direction information from tens of thousands of surface points on the eye instead of about a dozen used by conventional eye-tracking methods. The technique could boost eye-tracking accuracy in a variety of fields ranging from the entertainment industry to medical research and industrial engineering.

More Articles …